论文部分内容阅读
目的评价伊曲康唑治疗糖尿病合并侵袭性肺真菌病的疗效及安全性。方法对27例经伊曲康唑治疗的糖尿病合并侵袭性肺真菌病患者进行回顾性分析。结果 27例患者经治疗痊愈14例,显效6例,死亡4例,总有效率74.1,死亡率14.8。有9例出现轻度不良反应,占33.3。结论伊曲康唑唑治疗糖尿病合并侵袭性肺真菌病疗效及安全性均较高,一旦确诊,应尽早应用。
Objective To evaluate the efficacy and safety of itraconazole in the treatment of diabetes complicated with invasive pulmonary mycosis. Methods Twenty-seven patients with diabetes mellitus complicated with pulmonary fungal disease treated with itraconazole were retrospectively analyzed. Results 27 cases were cured after treatment in 14 cases, 6 cases markedly, 4 cases died, the total effective rate was 74.1, the mortality rate was 14.8. Nine patients had mild adverse reactions, accounting for 33.3. Conclusion The efficacy and safety of itraconazole in the treatment of diabetic patients with invasive pulmonary mycosis are high. Once diagnosed, it should be used as soon as possible.